CPI-0610, A BROMODOMAIN AND EXTRATERMINAL DOMAIN (BET) PROTEIN INHIBITOR, IN COMBINATION WITH RUXOLITINIB, IN JAK INHIBITOR-NAIVE MYELOFIBROSIS PATIENTS: UPDATE OF MANIFEST PHASE 2 STUDY

被引：0

作者：

Palandri, F. ^{[1
]}

Mascarenhas, J. ^{[2
]}

Harrison, C. ^{[3
]}

Patriarca, A. ^{[4
]}

Devos, T. ^{[5
,6
]}

Rampal, R. ^{[7
]}

Vannucchi, A. ^{[8
]}

Passamonti, F. ^{[9
]}

Mead, A. ^{[10
]}

Kremyanskaya, M. ^{[1
]}

Somervaille, T. ^{[11
,12
]}

Wondergem, M. ^{[13
]}

Hoffman, R. ^{[1
]}

Luptakova, K. ^{[14
]}

Wang, J. ^{[14
]}

Colak, G. ^{[14
]}

Shao, J. ^{[14
]}

Bobba, S. ^{[14
]}

Trojer, P. ^{[14
]}

Verstovsek, S. ^{[15
]}

Gupta, V. ^{[16
]}

机构：

[1] IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[2] Icahn Sch Med Mt Sinai, Div Hematol Med Oncol, Tisch Canc Inst, New York, NY 10029 USA

[3] Guys & St Thomas Hosp, London, England

[4] Azienda Osped Univ Maggiore Carita Novara SCDU Em, Novara, Italy

[5] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium

[6] Katholieke Univ Leuven, Lab Mol Immunol, Rega Inst, Leuven, Belgium

[7] Mem Sloan Kettering Canc Ctr, New York, NY USA

[8] Azienda Osped Univ Careggi, Florence, Italy

[9] Univ Insubria, Varese, Italy

[10] Oxford Univ Hosp, Oxford, England

[11] Canc Res UK Manchester Inst, Manchester, Lancs, England

[12] Christie Hosp, Manchester, Lancs, England

[13] Acad Ziekenhuis Vrije Univ, Dept Hematol, Amsterdam, Netherlands

[14] Constellat Pharmaceut, Cambridge, MA USA

[15] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[16] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada

来源：

HAEMATOLOGICA | 2021年 / 106卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

B008

引用

页码：5 / 6

页数：2